Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06989008 · ClinicalTrials.gov registry record

Enhancing Diabetes Care: Exposome &Amp; Sensors

A clinical trial of Type 2 Diabetes, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
20
Enrollment target
2
Study locations

NCT06989008 is a study of Type 2 Diabetes that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 20 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06989008, a study of Type 2 Diabetes, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study will focus on people with type 2 diabetes living in specified vulnerable zip codes.

Conditions Studied

Interventions

  • OTHER Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences

Study Locations (2)

Illinois

  • University of Illinois - Chicago - Chicago
  • University of Illinois College of Nursing - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-03-25
Est. Completion 2026-01-31

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT06989008

The ClinicalTrials.gov registry entry for NCT06989008 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences is the first listed.

NCT06989008 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06989008 about?

NCT06989008 is a clinical study titled "Enhancing Diabetes Care: Exposome &Amp; Sensors". The study aims to integrate various data types, such as electronic health records, wearable device data, and environmental data, to create a comprehensive, personalized diabetes care model. The study will focus on people with type 2 diabetes living in specified vulnerable zip codes.

What is the current status of trial NCT06989008?

This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-03-25. Estimated completion is 2026-01-31.

What conditions does trial NCT06989008 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT06989008?

The interventions under investigation include: Observational Study: Relationships Among Glucose, Physical Activity and Environmental Influences (OTHER).

Who is sponsoring clinical trial NCT06989008?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06989008 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.